Genetic variations in Ifih1 in humans are also associated with increased type I IFN signaling and an increased risk for the development of a number of autoimmune disorders, including Aicardi-Goutieres syndrome, systemic lupus erythematosus, and type I diabetes [56,74,75]. Here, IFIH1 is linked to autoimmune disease.